The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Lunch Activity/Non-CE-Accredited Satellite Symposium: PADCEV® (enfortumab vedotin-ejfv): Use as A Single Agent or In Combination With a PD-1 Inhibitor - 081-1005-PM <br>Seagen</br><br><i> Seating available on first-come, first-served basis</br></i>